Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Vesting of conditional share awards under the
GlaxoSmithKline Share Value Plan
This notification sets out the vesting of awards over Ordinary Shares and American Depositary Shares (ADS) in GlaxoSmithKline plc, made in 2012 under the GlaxoSmithKline Share Value Plan (SVP), which were conditional on continued employment with the GlaxoSmithKline group.
The restricted period for the 2012 SVP awards, which commenced on 22 August 2012, has now ended and the awards made have vested. The awards made to the connected person of a Person Discharging Managerial Responsibility (PDMR) vested on 17 February 2015 and details are given in the table below.
Name of Director / PDMR |
Name of Connected person |
Number of Ordinary Shares vested |
Number of ADS vested |
Dr M Slaoui* |
Mrs K Slaoui |
|
2,300 |
* Denotes an Executive Director
The Company and the above individual were advised of this transaction on 18 February 2015.
The fair market value of an ADS of GlaxoSmithKline plc at the point of vesting on 17 February 2015 was US$47.71.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
V A Whyte
Company Secretary
18 February 2015